Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin.
Mariniello M, Petruzzelli R, Wanderlingh LG, La Montagna R, Carissimo A, Pane F, Amoresano A, Ilyechova EY, Galagudza MM, Catalano F, Crispino R, Puchkova LV, Medina DL, Polishchuk RS.
Mariniello M, et al. Among authors: ilyechova ey.
Cancers (Basel). 2020 Mar 6;12(3):608. doi: 10.3390/cancers12030608.
Cancers (Basel). 2020.
PMID: 32155756
Free PMC article.